NASDAQ:CTMX
$2.77
(
-0.360%
)
Friday, 27th Jan 2023
CytomX Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.46 | $3.02 | Friday, 27th Jan 2023 CTMX stock ended at $2.77. This is 0.36% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 4.40% from a day low at $2.73 to a day high of $2.85. |
| 90 days | $1.17 | $3.02 | |
| 52 weeks | $1.17 | $4.73 |
Historical CytomX Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $2.75 | $2.85 | $2.73 | $2.77 | 1 365 547 |
| 2023-01-26 | $2.74 | $2.92 | $2.69 | $2.78 | 3 658 322 |
| 2023-01-25 | $2.74 | $2.74 | $2.56 | $2.62 | 1 358 008 |
| 2023-01-24 | $2.72 | $2.78 | $2.64 | $2.75 | 1 622 367 |
| 2023-01-23 | $2.57 | $2.80 | $2.49 | $2.73 | 3 304 190 |
| 2023-01-20 | $2.50 | $2.54 | $2.45 | $2.52 | 2 530 391 |
| 2023-01-19 | $2.55 | $2.59 | $2.46 | $2.50 | 2 015 748 |
| 2023-01-18 | $2.69 | $2.76 | $2.50 | $2.53 | 2 086 400 |
| 2023-01-17 | $2.86 | $2.86 | $2.62 | $2.67 | 1 827 806 |
| 2023-01-13 | $2.73 | $2.92 | $2.71 | $2.86 | 2 625 205 |
| 2023-01-12 | $2.75 | $2.88 | $2.61 | $2.73 | 3 648 900 |
| 2023-01-11 | $2.74 | $2.84 | $2.63 | $2.74 | 2 703 846 |
| 2023-01-10 | $2.82 | $2.95 | $2.67 | $2.78 | 4 822 900 |
| 2023-01-09 | $2.46 | $3.02 | $2.45 | $2.88 | 12 413 700 |
| 2023-01-06 | $2.96 | $2.98 | $2.34 | $2.52 | 51 298 900 |
| 2023-01-05 | $1.70 | $1.88 | $1.67 | $1.79 | 7 181 285 |
| 2023-01-04 | $1.61 | $1.69 | $1.59 | $1.67 | 1 602 239 |
| 2023-01-03 | $1.62 | $1.68 | $1.57 | $1.61 | 889 395 |
| 2022-12-30 | $1.55 | $1.61 | $1.50 | $1.60 | 771 744 |
| 2022-12-29 | $1.55 | $1.61 | $1.50 | $1.57 | 578 905 |
| 2022-12-28 | $1.47 | $1.54 | $1.46 | $1.54 | 814 136 |
| 2022-12-27 | $1.52 | $1.55 | $1.43 | $1.45 | 625 556 |
| 2022-12-23 | $1.57 | $1.57 | $1.51 | $1.55 | 404 966 |
| 2022-12-22 | $1.49 | $1.55 | $1.46 | $1.53 | 320 459 |
| 2022-12-21 | $1.52 | $1.56 | $1.50 | $1.51 | 475 508 |
| 2022-12-20 | $1.51 | $1.52 | $1.45 | $1.50 | 575 442 |
| 2022-12-19 | $1.57 | $1.58 | $1.49 | $1.53 | 948 551 |
| 2022-12-16 | $1.59 | $1.62 | $1.55 | $1.57 | 1 307 923 |
| 2022-12-15 | $1.61 | $1.64 | $1.59 | $1.59 | 303 016 |
| 2022-12-14 | $1.61 | $1.68 | $1.61 | $1.64 | 454 292 |
| 2022-12-13 | $1.55 | $1.68 | $1.54 | $1.63 | 954 024 |
| 2022-12-12 | $1.52 | $1.56 | $1.50 | $1.54 | 573 804 |
| 2022-12-09 | $1.59 | $1.64 | $1.33 | $1.55 | 2 442 967 |
| 2022-12-08 | $1.59 | $1.65 | $1.56 | $1.62 | 576 729 |
| 2022-12-07 | $1.67 | $1.67 | $1.57 | $1.58 | 778 035 |
| 2022-12-06 | $1.71 | $1.71 | $1.60 | $1.64 | 877 132 |
| 2022-12-05 | $1.70 | $1.78 | $1.67 | $1.71 | 882 631 |
| 2022-12-02 | $1.69 | $1.71 | $1.66 | $1.71 | 570 969 |
| 2022-12-01 | $1.72 | $1.74 | $1.66 | $1.71 | 702 910 |
| 2022-11-30 | $1.68 | $1.78 | $1.68 | $1.74 | 663 425 |
| 2022-11-29 | $1.71 | $1.73 | $1.63 | $1.70 | 951 053 |
| 2022-11-28 | $1.80 | $1.85 | $1.70 | $1.72 | 958 143 |
| 2022-11-25 | $1.81 | $1.84 | $1.78 | $1.81 | 440 353 |
| 2022-11-23 | $1.88 | $1.94 | $1.77 | $1.79 | 1 320 040 |
| 2022-11-22 | $1.67 | $1.92 | $1.62 | $1.91 | 3 076 400 |
| 2022-11-21 | $1.74 | $1.86 | $1.68 | $1.79 | 2 990 561 |
| 2022-11-18 | $1.62 | $1.78 | $1.55 | $1.71 | 6 066 046 |
| 2022-11-17 | $1.49 | $1.68 | $1.42 | $1.63 | 39 956 437 |
| 2022-11-16 | $1.20 | $1.25 | $1.17 | $1.20 | 351 931 |
| 2022-11-15 | $1.30 | $1.30 | $1.19 | $1.21 | 248 056 |
About CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
